Longname
BR serine/threonine kinase 2
3Letter
BR2
Accession
AF533878
Activation
N/A constitutive
Assay Method
BRSK2 (5-20mU diluted in 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1% β-mercaptoethanol, 1 mg/ml BSA) is assayed against a substrate peptide (KKLNRTLSFAEPG) in a final volume of 25.5 µl containing 50mM Tris pH 7.5, 0.1mM EGTA, 0.05% β-mercaptoethanol, 300 µM substrate peptide, 10 mM magnesium acetate and 0.05 mM [33P-γ-ATP] (50-1000 cpm/pmole) and incubated for 30 min at room temperature. Assays are stopped by addition of 5 µl of 0.5 M (3%) orthophosphoric acid and then harvested onto P81 Unifilter plates with a wash buffer of 50 mM orthophosphoric acid.
ATPGroup
50
Base36
22
Express
Off
ExpressionSys
Sf21 cells
KCode
74
Kinase Type
k
PDF
BRSK2.pdf
(75.16 KB)
Species
Human
TissRec
R